CA125 and HE4 measurements have also been combined with menopausal status to develop the risk of malignancy algorithm (ROMA), which has exhibited 94% sensitivity for ovarian cancer at 75% specificity [15]. The gene discussed is MUC16; the disease is ovarian carcinoma.